Back to the future: Alzheimer's disease heterogeneity revisited
- PMID: 27077132
- PMCID: PMC4827150
- DOI: 10.1016/j.dadm.2015.05.006
Back to the future: Alzheimer's disease heterogeneity revisited
References
-
- Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:280–292. - PMC - PubMed
-
- Lim Y.Y., Maruff P., Pietrzak R.H., Ames D., Ellis K.A., Harrington K. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain. 2014;137:221–231. - PubMed
-
- Lim Y.Y., Pietrzak R.H., Ellis K.A., Jaeger J., Harrington K., Ashwood T. Rapid decline in episodic memory in healthy older adults with high amyloid-β. J Alzheimers Dis. 2013;33:675–679. - PubMed
-
- Ellis K.A., Lim Y.Y., Harrington K., Ames D., Bush A.I., Darby D., AIBL Research Group Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. J Alzheimers Dis. 2013;34:861–871. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources